Stocks
Zynerba Pharmaceuticals (ZYNE) EBITDA margin US GAAP (year values) |
|||||||||
| FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -696.4% | -4 484% | -320 105% | -452 731% | -46 974% | |||
| Changes by years, y/y, % | -634pp | -3 787pp | -315 621pp | -132 626pp | +405 757pp | +276.6% | |||
Zynerba Pharmaceuticals. EBITDA margin, %
Zynerba Pharmaceuticals. EBITDA margin, changes, pp
Zynerba Pharmaceuticals (ZYNE) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2017Q4 | FY2018Q1 | FY2018Q2 | FY2018Q3 | FY2018Q4 | LTM ? | |||
| EBITDA margin, % | ? | -9 441% | ||||||
| Changes by years, y/y, % | ||||||||
| Changes by quarters, q/q, % | ||||||||
